Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drug Prices

The insurer Humana claims in a federal antitrust complaint that Mallinckrodt raised the price of the anti-inflammatory prescription drug Acthar from $40 a vial to more than $39,000 — “one of the most outrageous price-gouging schemes in the history of American medicine.”

LOS ANGELES — The insurer Humana claims in a federal antitrust complaint that Mallinckrodt raised the price of the anti-inflammatory prescription drug Acthar from $40 a vial to more than $39,000 — “one of the most outrageous price-gouging schemes in the history of American medicine.”

Categories / Business, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...